Stay updated on Cabozantinib and Nivolumab in Endometrial Cancer Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib and Nivolumab in Endometrial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib and Nivolumab in Endometrial Cancer Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The page now displays Revision: v3.6.6, indicating a new build behind the scenes. No study content or navigation changes are indicated.
    Difference
    0.0%
    Check dated 2026-09-01T19:54:24.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    14 days ago
    Change Detected
    Summary
    Date entries were added and older dates removed in the study record, updating the trial timeline and reporting milestones. These updates reflect administrative changes to scheduling and documentation rather than the study's scientific content.
    Difference
    0.2%
    Check dated 2026-08-18T20:00:17.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.4 to v3.6.5 on the page, signaling a small update to the site. This change does not modify the study details or visible content.
    Difference
    0.0%
    Check dated 2026-08-11T19:17:23.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.3 to v3.6.4, signaling a small update to the page version.
    Difference
    0.0%
    Check dated 2026-07-21T12:46:38.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.0 to v3.6.3. This change reflects a newer build of the page content rather than a substantive modification.
    Difference
    0.0%
    Check dated 2026-06-30T01:25:41.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    The study page now indicates it is no longer recruiting participants, and new help sections (How to Read a Study Record, Common Questions, How to Join a Study) were added, while the Intervention/Treatment header was renamed from Intervention / Treatment and the revision label updated to v3.6.0.
    Difference
    0.3%
    Check dated 2026-06-15T20:04:01.000Z thumbnail image

Stay in the know with updates to Cabozantinib and Nivolumab in Endometrial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib and Nivolumab in Endometrial Cancer Clinical Trial page.